| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Vitoc Vlad | 9.7% | $4,307,914 | 3,846,352 | Vlad Vitoc | 21 Nov 2025 | |||
| FGMK Business Holdings, LLC | 10% | $6,068,078 | 2,889,561 | FGMK Business Holdings, LLC | 14 Sep 2024 | |||
| Gryaznov Sergei | 4.1% | $2,394,242 | 1,140,115 | Sergei M. Gryaznov | 31 Dec 2023 |
As of 30 Sep 2025, 19 institutional investors reported holding 2,373,804 shares of MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value (MAIA). This represents 6% of the company’s total 39,817,308 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 14,800 | $22,644 | $1.53 | 1 | |
| 2025 Q3 | 2,373,804 | $3,487,006 | +$129,244 | $1.54 | 19 |
| 2025 Q2 | 2,284,355 | $3,952,129 | +$1,392,212 | $1.80 | 20 |
| 2025 Q1 | 1,477,270 | $2,261,254 | +$114,552 | $1.53 | 20 |
| 2024 Q4 | 1,390,935 | $2,754,258 | -$193,537 | $1.98 | 20 |
| 2024 Q3 | 1,467,276 | $4,148,452 | -$930,566 | $2.81 | 17 |
| 2024 Q2 | 1,788,020 | $6,092,876 | +$3,928,913 | $3.42 | 20 |
| 2024 Q1 | 660,884 | $1,502,744 | -$141,291 | $2.20 | 19 |
| 2023 Q4 | 803,162 | $957,759 | +$550,428 | $1.17 | 21 |
| 2023 Q3 | 318,278 | $699,643 | -$8,833 | $2.20 | 13 |
| 2023 Q2 | 321,911 | $709,089 | +$545,884 | $2.20 | 11 |
| 2023 Q1 | 71,531 | $246,685 | +$83,630 | $3.45 | 6 |
| 2022 Q4 | 297,126 | $1,043,412 | +$236,126 | $3.51 | 6 |
| 2022 Q3 | 231,277 | $763,000 | +$763,000 | $3.30 | 7 |